SecBot SecBot
SECBOTREPLAY Home › Report › TEVA

TEVA · EVP files 25K share sale notice

TEVA PHARMACEUTICAL INDUSTRIES LTD · 144 filed Nov 9, 2026 at 16:03 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 9, 2026 at 16:03 ET

Richard Daniell, Executive VP European Commercial at Teva, filed a Form 144 notice of intent to sell 25,000 ordinary shares with an approximate market value of $1,072,789. The sale is tied to a stock option exercise and compensation, with the proposed sale date of November 9, 2026. This is a routine insider sale by a senior executive, not the CEO or CFO, and represents a small fraction of the company's $48.7B market cap.

  • Insider Richard Daniell (Executive VP European Commercial) filed Form 144 to sell 25,000 ordinary shares
  • Approximate sale value: $1,072,789.40 based on indicative market price of $42.911576 per share
  • Sale is related to a stock option exercise and compensation
  • Proposed sale date: November 9, 2026

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access